```html

Extravasation (Bleeding Under Skin)

What is Extravasation (bleeding under skin)?

Extravasation is the leakage of fluid—most commonly blood or medication—from a vessel into the surrounding tissue. When the fluid is blood, the term is often used interchangeably with “subcutaneous hemorrhage” or “bruising.” The leaked blood pools beneath the skin, creating a discoloration that may be flat, raised, or tender to the touch. While a small bruise is usually harmless, extensive extravasation can compress nerves, compromise circulation, or become infected, especially when it follows an IV infusion or trauma.

In medical contexts, “extravasation” is also used to describe the accidental infusion of vesicant drugs (e.g., chemotherapy agents) into tissues. This article focuses on the more common occurrence of blood extravasation but also touches on drug‑related extravasation because the management principles overlap.

Common Causes

• Trauma or blunt injury – falls, sports injuries, or accidental bumps that rupture capillaries.
• Intravenous (IV) therapy – improper catheter placement or dislodgement can let blood or medication seep into the surrounding tissue.
• Anticoagulant or antiplatelet medications – warfarin, heparin, aspirin, clopidogrel, and newer agents such as dabigatran increase bleeding risk.
• Bleeding disorders – hemophilia, von Willebrand disease, or acquired clotting factor deficiencies.
• Needle stick injuries – venipuncture, blood draws, or injections that puncture a vessel.
• Vasculitis or inflammatory vessel disease – conditions like Henoch‑Schönlein purpura cause fragile vessels.
• Skin‑related infections – cellulitis or necrotizing fasciitis can erode vessels, leading to bleeding under the skin.
• Heavy or repetitive pressure – prolonged compression (e.g., tight casts, compression stockings) can cause small vessel rupture.
• Systemic illnesses – liver disease, vitamin K deficiency, or thrombocytopenia (low platelet count) impair clot formation.
• Chemotherapy or other vesicant drugs – accidental infiltration during infusion can cause tissue necrosis and bleeding.

Associated Symptoms

While many extravasations are painless bruises, larger or more severe leaks may be accompanied by:

• Pain or throbbing sensation at the site
• Swelling or a palpable lump
• Redness that turns purple, blue, or greenish as the bruise ages
• Warmth or a feeling of “tightness” over the area
• Limited range of motion if the bleed is near a joint
• Skin discoloration that spreads outward (sentinel sign for drug extravasation)
• Fever, chills, or malaise if infection develops
• Bleeding from the surrounding skin or an open wound

When to See a Doctor

Most bruises resolve on their own within 1–2 weeks. Seek professional care if you notice any of the following:

• Severe pain that does not improve with over‑the‑counter pain relievers.
• Rapid swelling or a feeling of pressure that could compromise circulation.
• Bruising that expands in size after the initial injury.
• Skin that becomes warm, red, or blistered—signs of infection or drug‑induced tissue damage.
• Bleeding that does not stop after applying firm pressure for 10–15 minutes.
• Any bruising that occurs spontaneously (no obvious trauma) especially if you are on blood thinners.
• Signs of anemia (fatigue, shortness of breath, pale skin) after a large bleed.
• Persistent bruising in children or the elderly without a clear cause.

Diagnosis

Healthcare providers use a combination of history, physical examination, and—when needed—diagnostic tests to determine the cause and extent of extravasation.

1. Medical history – recent injuries, IV/infusion therapy, medications (especially anticoagulants), and known bleeding disorders.
2. Physical examination – inspection for size, color, and texture of the bruise; palpation for tenderness, fluctuance (fluid collection), or firm masses.
3. Imaging (if indicated)
   • Ultrasound – evaluates the depth of the bleed and distinguishes it from a hematoma or abscess.
   • CT or MRI – reserved for deep or compartment‑syndrome‑type bleeds, especially near joints or the spine.
4. Laboratory studies (often ordered when a bleeding disorder is suspected)
   • Complete blood count (CBC) – platelet count.
   • Prothrombin time (PT) / International Normalized Ratio (INR) – clotting cascade.
   • aPTT – intrinsic pathway function.
   • Specific factor assays for hemophilia or vitamin K levels.
5. Drug‑related extravasation assessment – clinicians will review infusion records, the type of drug, and the time elapsed since the incident.

References: Mayo Clinic; CDC; National Hemophilia Foundation.

Treatment Options

Treatment is tailored to the severity of the extravasation, the underlying cause, and patient‑specific factors.

Immediate Home Care (for mild bruises)

• Cold compress – 10‑15 minutes every 1–2 hours for the first 24–48 hours to limit swelling.
• Elevation – keep the affected limb above heart level when possible.
• Compression – gentle elastic bandage (not too tight) after 48 hours if swelling persists.
• Analgesics – acetaminophen or ibuprofen (if not contraindicated by bleeding risk).
• Topical arnica or vitamin K creams – may improve bruising resolution, though evidence is modest.

Medical Interventions

• Pressure dressings – for larger hematomas to limit further leakage.
• Needle aspiration or drainage – performed by a clinician for sizable, painful subcutaneous hematomas.
• Antidotes for drug extravasation – e.g., hyaluronidase for certain chemotherapeutic agents, or sodium thiosulfate for mechlorethamine.
• Reversal of anticoagulation – Vitamin K, protamine sulfate, or specific reversal agents (idarucizumab, andexanet alfa) when bleeding is significant.
• Blood product transfusion – packed red cells or platelets for patients with active major bleeding or severe anemia.
• Surgical consultation – if compartment syndrome, ongoing arterial bleed, or necrotic tissue from vesicant drug exposure is suspected.

Follow‑up Care

• Schedule a follow‑up visit within 1–2 weeks to ensure resolution.
• Repeat imaging or labs if symptoms worsen.
• Educate patients on signs of infection or re‑bleeding.

Prevention Tips

• Use proper technique for IV placement – verify blood return, secure the catheter, and rotate sites per hospital protocol.
• Apply a tourniquet correctly – no longer than 1 minute and not too tight.
• Monitor anticoagulated patients – keep INR within therapeutic range; adjust dosages with regular lab checks.
• Protect skin integrity – avoid tight clothing, casts, or bandages that compress vessels.
• Strengthen vessel health – maintain a balanced diet rich in vitamin C, K, and bioflavonoids, and stay hydrated.
• Promptly treat minor injuries – clean cuts, apply pressure, and keep wounds covered.
• Educate caregivers – especially for children, the elderly, or patients on blood thinners, about recognizing early bruising.
• Review medication list – discuss with health‑care providers before starting new drugs that affect clotting.

Emergency Warning Signs

Key Take‑aways

Extravasation—or bleeding under the skin—is usually benign but can signal serious underlying problems, especially when it follows IV therapy, occurs in patients on anticoagulants, or is accompanied by pain, swelling, or systemic symptoms. Prompt recognition, appropriate first‑aid measures, and timely medical evaluation are essential to prevent complications such as infection, compartment syndrome, or tissue loss. Always discuss any unexpected bruising with a health‑care professional, and follow preventive strategies to reduce future risk.

References:

• Mayo Clinic. “Bruise (contusion).” 2023.
• Centers for Disease Control and Prevention. “Bleeding Disorders.” Updated 2022.
• National Institutes of Health. “Anticoagulant Therapy: Managing Bleeding Risks.” 2021.
• Cleveland Clinic. “Extravasation Injuries: Prevention and Management.” 2022.
• World Health Organization. “Guidelines for Safe Injections.” 2020.

```